IP Library Granted Patent US 9,765,384
Granted Patent B2
US 9,765,384 · App. 14/012,622 · Granted Sep 19, 2017

Methods and compositions for inhibiting undesired cleaving of labels

Inventors: Jerzy Olejnik (Brookline, MA); Evan Guggenheim (Brookline, MA); Visalakshi Visalakshi (Ashland, MA)
Assignee: Intelligent BioSystems, Inc.
C12Q1/6806C12Q1/6825C12Q1/6869G06F19/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,765,384
App. No.
14/012,622
Granted
Sep 19, 2017
Kind
B2
Abstract

The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.

Claims (15)

1. A composition comprising a cleaving agent scavenger and one or more nucleotide analogues in solution, said scavenger comprising cystamine, said analogues labeled with a unique label attached through a cleavable linker.

2. The composition of claim 1 , wherein said unique label is attached through a cleavable disulfide linker.

3. The composition of claim 1 , wherein said unique label is attached through a cleavable azido linker.

4. The composition of claim 1 , wherein said one or more nucleotide analogues comprise a removable chemical moiety capping the 3′-OH.

5. The composition of claim 4 , wherein said chemical moiety comprises a disulfide bond.

6. The composition of claim 4 , wherein said chemical moiety comprises an azido group.

7. The composition of claim 4 , wherein said chemical moiety comprises an azidomethyl ether.

8. The composition of claim 1 , further comprising a polymerase.

9. A system comprising reservoirs in fluid communication with a reaction chamber, at least one of said reservoirs comprising a solution comprising a cleaving agent scavenger and one or more nucleotide analogues, said scavenger comprising cystamine, said analogues labeled with a unique label attached through a cleavable linker.

10. The system of claim 9 , wherein said unique label is attached through a cleavable disulfide linker.

11. The system of claim 9 , wherein said unique label is attached through a cleavable azido linker.

12. The system of claim 9 wherein said one or more nucleotide analogues comprise a removable chemical moiety capping the 3′-OH.

13. The system of claim 12 , wherein said chemical moiety comprises a disulfide bond.

14. The system of claim 12 , wherein said chemical moiety comprises an azido group.

15. The system of claim 12 , wherein said chemical moiety comprises an azidomethyl ether.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: ISOPLEXIS CORPORATION
Reel/Frame 063235/0942 →
PATENT PURCHASE AGREEMENT Recorded Jul 30, 2021
From: QIAGEN SCIENCES, LLC
To: ISOPLEXIS CORPORATION
Reel/Frame 057043/0629 →
SECURITY AGREEMENT Recorded May 28, 2021
From: ISOPLEXIS CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 056421/0929 →
MERGER Recorded Nov 8, 2018
From: QIAGEN WALTHAM, INC.
To: QIAGEN SCIENCES, LLC
Reel/Frame 047923/0815 →
CHANGE OF NAME Recorded May 17, 2018
From: INTELLIGENT BIO-SYSTEMS, INC.
To: QIAGEN WALTHAM, INC.
Reel/Frame 047132/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2013
From: OLEJNIK, JERZY; GUGGENHEIM, EVAN; VISALAKSHI, VISALAKSHI
To: INTELLIGENT BIO-SYSTEMS, INC.
Reel/Frame 031320/0025 →
Continuity (3)
Continuation 12405866 · Mar 17, 2009
Provisional Application 61037845 · Mar 19, 2008
Related Publication 20140234832A1 · Aug 21, 2014